Transcription
2021 Pfizer Fellowship Programin partnership withInstitute for PharmaceuticalIndustry Fellowships
TABLE OF CONTENTSOur Values and Behaviors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3Diversity & Inclusion – As Diverse as the Patients and Communities We Serve . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 4Introduction to the Pfizer Fellowship Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .5-6Introduction to the Pfizer Fellowship Leadership Team . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 7Our Current Fellows. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 8US and Global Medical Affairs – Oncology Fellowship Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 9-11Global Medical Information (GMI)/Internal Medicine, Global Medical Affairs (GMA) – Fellowship Overview. . . . . . . . . . . . . . . . . . . . . . 12-15North America Medical Affairs (NAMA)/Global Medical Affairs (GMA) – Internal Medicine Fellowship Overview. . . . . . . . . . . . . . . . . . 16-17North America Medical Affairs (NAMA)/Global Medical Affairs (GMA) – Hospital Business Fellowship Overview . . . . . . . . . . . . . . . . . . 18-20Global Medical Affairs (GMA) – Inflammation & Immunology Fellowship Overview. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 21-23US Medical Affairs – Rare Disease Fellowship Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 24-26Clinical Development & Operations Fellowship Overview. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27Risk Management Center of Excellence/U.S. Food and Drug Administration (RMCoE/FDA) – Risk Management Fellowship Overview. . . . . . . 28-29Alumni Spotlight . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30Pfizer Pharmacy Networks . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31Rutgers Pharmaceutical Industry Fellowship Program . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 32-362021 PFIZER FELLOWSHIP PROGRAM2
Our Values and BehaviorsCourageCourageBreakthroughs thatchange patients’ livesExcellenceEquityJoyExcellenceEquityJoyThink bigFocus on what mattersWe pursuedaring ideas—favor the bold.becausebreakthroughsbecause breakthroughs favor the bold.We prioritizewhatis important—becausegettingthosefew things rightbecause getting those few things rightcan make all the difference.can make all the difference.Think bigWe pursue daring ideas—SpeakSpeakupupWe saywhat’sononourour mind—We saywhat’smind—because candor makes us stronger.because candor makes us stronger.Be decisiveBeWedecisivemake choices—because time and resources are precious.We makechoices—because time and resources are precious.2021 PFIZER FELLOWSHIP PROGRAMFocus onmattersWe prioritizewhatwhatis important—AgreewhatAgreewhowho doesdoes whatWe e assignclearbecause effective collaboration dependsbecauseeffective collaboration dependson clarity.on clarity.Be inclusiveBe inclusiveWe respect all people for who they are—We respectall peoplefor uswhothey are—becausediversityraisesall.Take prideWe celebrateour impact—We celebrateour changesimpact— patients’ lives.becauseour erRecognize oneone anotherWe alwaystherightright thing—We alwaysdodothething—because patients’ lives depend on us.because patients’ lives depend on us.We honorourcolleaguescolleagues andtheirefforts—We honorourandtheirefforts—because praise sparks passion.becausepraise sparks passion.because diversity raises us all.Reduce healthcareMeasureoutcomesWe always use metrics—ReducehealthcaredisparitiesdisparitiesWe strive to serve all patients—because you can’t manage what youcan’t measure.because everyone should have a chanceto be healthy.Measure outcomesbecause you can’t manage what youWe alwaysuse metrics—can’t measure.Take pridebecause everyone should have a chanceWe striveto serve all patients—to be healthy.because our work changes patients’ lives.Have funHavefunWe can always make room to be playful—because laughter is good medicine, too.We can always make room to be playful—because laughter is good medicine, too.3
Diversity & Inclusion –As Diverse as the Patients and Communities We ServeOUR PURPOSE AT PFIZER IS CLEAR: ACHIEVINGBREAKTHROUGHS THAT CHANGE PATIENTS’ LIVESWe realize that means not just attracting the best and brightest talent. But also ensuring ourcolleagues can thrive in an environment and culture where we champion Diversity and Inclusionevery day, around the world.EQUITY RUNS THROUGH EVERYTHING WE DOWe want all patients to have equal access to healthcare, and accessible and affordable drugs.Within our business, we believe everyone deserves to be seen, heard and respected for whothey are.That’s why we focus and invest in making Pfizer an amazing workplace for all. Our Diversity &Inclusion Leads around the world partner with Business Leaders to make sure our approachand processes reflect our key values.BUT THIS ISN’T JUST ABOUT WHAT WE DO AS A BUSINESSIt’s about who we are. We want all our colleagues to develop, grow, and succeed. We committo making that happen, and to sharing and celebrating our successes as we bring togetherpeople from all backgrounds, geographies and perspectives.Careers.pfizer.com2021 PFIZER FELLOWSHIP PROGRAM4
Introduction to the Pfizer Fellowship ProgramGREETINGS FROM OUR CHIEF MEDICAL OFFICER!I would like to extend a warm welcome to our partners at Rutgers University and to those candidates who are considering the RutgersPharmaceutical Industry Fellowship (RPIF) Program.One of Pfizer’s strengths is found in the many talented colleagues who advance biomedical innovation through a host of medical and clinicalresearch specialties. Our overarching goal is placing patients at the center of everything we do, ensuring that patient voices are both heard andheeded throughout the innovation process. As you will read in the coming pages, Pfizer has a partnership with Rutgers and greatly supportsthe RPIF program, through which Fellowship Alumni have gone on to a wide range of leadership opportunities within Pfizer—and our industry.Through this process, we invite you on a journey of personal and professional exploration. You will come to learn that Pfizer colleagues areamong the best in our industry and firmly dedicated to creating and delivering Breakthroughs That Change Patients’ Lives.I wish you great success throughout this process and in your future endeavors.Mace Rothenberg, MDChief Medical OfficerPfizer Inc2021 PFIZER FELLOWSHIP PROGRAM5
Introduction to the Pfizer Fellowship ProgramWELCOME FROM OUR FELLOWSHIP DIRECTOR!Since its creation, the RPIF program at Pfizer has expanded to numerous areas and has graduated over 60 fellows, many of whom remainwith the company. There is ample opportunity to establish a rewarding career in a number of areas.The RPIF program at Pfizer is well-established, with support at the highest levels of the company. The leadership team, composed of strongadvocates for the fellows, includes executive sponsors, program directors, and a chief fellow. The RPIF program at Pfizer also maintainsstrong connections to other post-doctoral programs across the company as well as employee resource groups such as the Pfizer PharmacistsAssociation (PPA). Over the coming year, the leadership team will be working hard on behalf of all our key stakeholders to continueimproving the program.Together with the other key stakeholders for the program, we want to thank you for your interest in Pfizer as the company with which topursue your fellowship. We wish you good luck throughout the interview process and in starting the next phase of your career!Lisa Tarasenko, BS, PharmD, MBASenior Medical Director, Global Medical Affairs,Internal Medicine Early Asset LeadFellowship Director, Pfizer/RPIF Program2021 PFIZER FELLOWSHIP PROGRAM6
Introduction to the Pfizer Fellowship Leadership TeamPfizer Fellowship Leadership TeamFellowship DirectorLisa Tarasenko, BS, PharmD, MBASenior Director, Internal MedicineEarly Asset LeadExecutive SponsorsJulia Perkins-Smith, MDGlobal Clinical Lead,OncologyAndrew Coop, MBChB,BSc HonsVP, NA Medical Affairs OncologyChief FellowDavid A. DeMicco, PharmDVP, Head of Global MedicalAffairs, Internal MedicineEhab Mahgoub, MDHead of I&I North AmericaMedical AffairsArianna Burton, PharmDFellow, US Medical Affairs,Rare DiseaseProgram DirectorsPfizer Innovative HealthProgram CoordinatorLydia DouglassExec Admin AssistantOncologyHospitalSergio Gatoulis, PharmD Mary Baker PharmD, MBA, FASPENMedical Director, PfizerOncologySenior Director, Sterile InjectablesHospital Business UnitNAMA/GMA – I&IGMI / GMAArif Soonasra, PharmDStacey Follman, PharmDSr. Medical Director, BiosimilarsDirector Student Affairs,Medical InformationHR CoordinatorRare DiseaseNAMA / GMA – IMClinical DevelopmentRichard TreacyAlex Schepart, PharmD, MBALisa Tarasenko, BS, PharmD, MBAAnthony Porcari, PharmD, PhDHuman Resources LTMember2021 PFIZER FELLOWSHIP PROGRAMDirector, NA Rare Disease Medical AffairsSenior Director Early Asset LeadClinical Program Lead CD&O7
Our Current FellowsSECOND-YEAR FELLOWSInflammation & ImmunologyRare DiseaseArianna Burton, PharmDUS Medical AffairsHelen Tran, PharmDGlobal Medical AffairsSarah Ofori, PharmD, MBAGlobal Medical AffairsGMI / GMAChristine Joseph, PharmDGMA Internal MedicineFIRST-YEAR FELLOWSOncologyJuan Razo, PharmDDavid Giang, PharmDUS/Global Medical AffairsAlexander Agyei Marfo, PharmDUS/Global Medical AffairsUS Medical AffairsCaroline DiCristo, PharmDInflammation & ImmunologyNorth America Medical AffairsElpitha Soussou, PharmD, MBAUS/Global Medical AffairsFELLOWSHIPS RECRUITING:Pooja Shah, PharmD, MSNorth America Medical AffairsInternal MedicineHospitalNino Katchiuri, PharmDDomenick Francis, PharmDNAMA/GMAGMI / GMAFarah Pragga, PharmDGMI OncologyNAMA/GMAUS/Global Medical Affairs, Oncology 1 Fellow [2 years, NY Headquarters]Global Medical Affairs, Inflammation & Immunology 4 Fellows [2 years, NY Headquarters/Collegeville, PA]NEWClinical Development and Operations1 fellow [2 years, Flexible location]US Medical Affairs, Rare Disease 1 Fellow [2 years, NY Headquarters]North America/Global Medical Affairs, Internal Medicine1 Fellow [2 years, NY Headquarters]NEWRisk Management Center of Excellence1 fellow [2 years, NY Headquarters]North America/Global Medical Affairs, Hospital Business Unit 1 Fellow [2 years, NY Headquarters]Global Medical Information/ Internal Medicine, Global Medical Affairs 1 Fellow [2 years, NY Headquarters]2021 PFIZER FELLOWSHIP PROGRAM8
US and Global Medical Affairs – Oncology Fellowship OverviewOVERVIEW OF ONCOLOGYAt Pfizer, we apply science and our global resources to bring therapies to people that extend and significantly improve their lives. We striveto set the standard for quality, safety and value in the discovery, development and manufacture of health care products, including innovativemedicines and vaccines.Within our Oncology unit, we are striving to change the trajectory of cancer. We have an industry-leading portfolio of more than 20 approvedinnovative cancer medicines and biosimilars across more than 30 indications, including breast, prostate, kidney, and lung cancers, as well asleukemia and melanoma.Every day, Pfizer colleagues work across developed and emerging markets toadvance wellness, prevention, treatments and cures that challenge the mostfeared diseases of our time.Supporting these efforts are teams of dedicated colleagues focused on understanding thespecific needs of people living with cancer and providing support to oncology investigators,practitioners and caregivers. Among these interconnected teams are the US and GlobalMedical Affairs teams, who both play integral roles in the drug development continuum.2021 PFIZER FELLOWSHIP PROGRAMDany Habr, MDSVP & Chief Medical OfficerPfizer Oncology9
US and Global Medical Affairs – Oncology Fellowship OverviewRECRUITINGThe purpose of this Fellowship program is to provide PharmDs with the skills and experiences needed to launch a successful career in thepharmaceutical industry through specialized training in Oncology Medical Affairs. The Pfizer Oncology Medical Affairs Fellowship offersa broad overview of important areas within the pharmaceutical industry and provides valuable networking opportunities for PharmDs.Fellows will expand their clinical knowledge by gaining exposure, within Oncology, to a range of therapeutic areas and treatments that mayinclude: breast, hematology, lung, renal cell carcinoma, prostate, melanoma, biosimilars, and immuno-oncology. Fellows will be expectedto work closely with Medical Directors and provide support through active participation in the development and execution of a broad rangeof Medical Affairs activities.For 2021, Pfizer Oncology is recruiting to fill one 2-year fellowship position in Medical Affairs:Two-year Fellowship – July 2021 to June 2023 (1 Position) The position will provide exposure to both US and Global Medical AffairsDevelop critical interaction skills and build anetwork:Transfer knowledge and become a valuedteam member:Gain experience in the operationalaspects of industry:––Collaborate with cross-functional teams including:––Provide medical review of promotional––Plan and coordinate medical advisory board––Provide input regarding the development of––Research, create, and review medical responseMarketing, Commercial, Communications,Regulatory Affairs, Legal, Outcomes Research,and Clinical Research and Development––Attend regional and national scientific andmedical conferences and report key findings––Participate in Lunch & Learn meeting series tolearn about various roles from cross-functionalcolleagues––Support collaboration with key stakeholdersto develop strategy, implement studies, andinterpret datamaterialsmedical publications and ensure the scientificaccuracy of manuscripts––Participate in medical slide development andreview, including training documents for fieldbased colleagues––Provide insight to team members regardingcurrent practices and potential futureparadigm shiftsmeetingsletters and dossiers to ensure fair andscientifically balanced responses to medicalinquiries––Support appropriate dissemination of clinicaltrial results and real world evidence––Partner with field-based medical colleaguesin supporting investigator-led studies,research activities, and communications withhealthcare professionals––Interact with key medical opinion leaders andother healthcare practitioners2021 PFIZER FELLOWSHIP PROGRAM10
US and Global Medical Affairs – Oncology Fellowship OverviewMEDICAL AFFAIRS – ONCOLOGYCaroline Hoang, PhDTeam LeadUS Oncology Medical AffairsPRECEPTORYao Wang, MDSenior Medical DirectorGlobal Oncology Medical AffairsPRECEPTORGeeta Devgan, PhDSenior Medical DirectorUS Oncology Medical AffairsPRECEPTORGustavo Rodriguez, PharmDMedical DirectorUS Oncology Medical AffairsPRECEPTORSergio Gatoulis, PharmDMedical Director,US Oncology Medical AffairsPROGRAM DIRECTORElpitha Soussou, PharmD, MBAUS/Global Oncology Medical AffairsFELLOW2021 PFIZER FELLOWSHIP PROGRAMCaroline DiCristo, PharmDUS/Global Oncology Medical AffairsFELLOWDavid Giang, PharmDUS Oncology Medical AffairsFELLOWJuan Razo, PharmDUS/Global Oncology Medical AffairsFELLOW11
Global Medical Information (GMI)/Internal Medicine, Global Medical Affairs (GMA) Fellowship OverviewDominick Albano, PharmD, MBAVice PresidentGlobal Medical InformationSTAKEHOLDERDavid A. DeMicco, PharmDVice PresidentHead of Global Medical Affairs, Internal MedicineEXECUTIVE SPONSORGLOBAL MEDICAL INFORMATION:GLOBAL MEDICAL AFFAIRS, INTERNAL MEDICINE:The mission of GMI is to empower our customers to make informeddecisions through quality interactions that benefit patients.The mission of Global Medical Affairs, Internal Medicine is to enhancethe knowledge of our medicines and the associated therapeuticareas in which we focus our research efforts and interpret emergingscientific trends, clinical data, and the competitive landscape andalign internal stakeholders on a balanced benefit-risk proposition.Global Medical Information aims to strengthen Pfizer’s mission andpurpose by ensuring easy to access and easy to use informationand knowledge that significantly impacts patient care. Our productexpertise and customer interactions enable us to share valuableinsights with our internal partners and to develop innovative solutionsthat support the Medical Information needs of our customers.2021 PFIZER FELLOWSHIP PROGRAMOur purpose is to create, demonstrate, and communicate the clinicalvalue of our medicines while maintaining patient’s best interests.Global Medical Affairs, Internal Medicine leads scientific dialoguewith the medical and scientific communities in an accurate, fair, andbalanced manner about the benefits and the risks of our medicines.This enables prescribers and other healthcare decision makers tomake informed decisions with patients and use our medicines safelyand effectively.12
Global Medical Information (GMI)/Internal Medicine, Global Medical Affairs (GMA) Fellowship OverviewRECRUITINGFIRST YEAR: GLOBAL MEDICAL INFORMATION*The GMI fellow takes on the roles and responsibilities of a Medical Information Manager. This fellow will be exposed to the foundationalelements of medical information (MI) and have the opportunity to work in our MI community locally, regionally, and globally. In addition, thefellow will work cross functionally on various projects throughout other Pfizer business units. Responsibilities include but are not limited to:Understanding the medicine, thetherapeutic area, and the informationneeds of the medical community,patients, and caregivers:––Develop and leverage expertise as a subjectmatter expert for assigned Pfizer product(s)and associated therapeutic area(s)––Proactively analyze inquiry data to identifycustomer insights, trends and subsequentlyconstruct and execute strategic action planswhen key medical and customer issues areidentifiedGenerating valued clinical and scientificresponses to assist in making informedhealthcare decisions:Communicating to customers andstakeholders to facilitate the safe andeffective use of Pfizer prescription products:––Perform in-depth research, analysis, and––Provide balanced, scientific, and evidence-based––Research unsolicited MI inquiries by utilizing––Contribute to the management ofinterpretation of the medical literature fromboth external and internal sourcesmedical resources, clinical knowledge, andscientific literature––Actively participate in the creation andmaintenance of regional and globalMI scientific response documents byensuring that responses are medically andscientifically accurate, timely, fair-balanced,and meet customer needsanswers to unsolicited medical questions fromour customersproductissues and business objectives by collaboratingwith Medical Affai
As you will read in the coming pages, Pfizer has a partnership with Rutgers and greatly supports . Lisa Tarasenko, BS, PharmD, MBA Senior Medical Director, Global Medical Affairs, Internal Medicine Early Asset Lead Fellowship Director, Pfizer/RPIF Program Introducti
